CORMEDIX INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CORMEDIX INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-09-30 was 13.81M shares.
- CORMEDIX INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-06-30 was 3.12M shares.
- CORMEDIX INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-03-31 was 10.20M shares.
- CORMEDIX INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2017-12-31 was 0.00 shares.
- CORMEDIX INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2017 was 10.00K shares.
- CORMEDIX INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2016 was -1.09M shares.
- CORMEDIX INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2015 was -499.95K shares.
- CORMEDIX INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2014 was -455.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2018-09-30 | 13.81M shares 10-Q · filed 2018-11-14 | 27.13M shares derived: sum of 4 quarters · filed 2018-11-14 |
| 2018-06-30 | 3.12M shares 10-Q · filed 2018-08-14 | 13.32M shares derived: sum of 4 quarters · filed 2018-08-14 |
| 2018-03-31 | 10.20M shares 10-Q · filed 2018-05-15 | |
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | 10.00K shares 10-K · filed 2018-03-19 |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | |
| 2016-12-31 | -1.09M shares 10-K · filed 2017-03-16 | |
| 2015-12-31 | -499.95K shares 10-K · filed 2016-03-15 | |
| 2014-12-31 | -455.00K shares 10-K · filed 2016-03-15 | |
| 2013-12-31 | -10.00K shares 10-K · filed 2015-03-12 | |
| 2012-12-31 | 0.00 shares 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |